Advertisement
Xeris Biopharma Holdings, Inc. (XERS)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Follow
As of 11:23AM EST. Market open.
| Previous Close | 3.0800 |
| Open | 3.0800 |
| Bid | 3.0900 x 100 |
| Ask | 3.2100 x 100 |
| Day's Range | 3.0800 - 3.1700 |
| 52 Week Range | 1.6900 - 3.6400 |
| Volume | |
| Avg. Volume | 1,583,587 |
| Market Cap | 470.351M |
| Beta (5Y Monthly) | 1.28 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.4300 |
| Earnings Date | Nov 08, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 4.77 |
Business WireXeris to Participate in Piper Sandler 36th Annual Healthcare Conference
CHICAGO, November 26, 2024--Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patients’ lives by developing and commercializing innovative products across a range of therapies, today announced that members of its senior management will participate in a fireside chat at the upcoming Piper Sandler 36th Annual Healthcare Conference on December 3, 2024 at 8:00am Eastern Time.
Simply Wall St.Analysts Expect Breakeven For Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Before Long
With the business potentially at an important milestone, we thought we'd take a closer look at Xeris Biopharma...
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.